Manufacturer Supply High Purity Gemcitabine HCl Powder CAS 122111-03-9

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: 011302
• Certification: ISO 9001
• Suitable for: Adult
• State: Powder
• Purity: >99%
• Appearance: White Powder
• Molecular Formula: C9h12clf2n3o4
• MW: 299.66
• Certificate: ISO 9001, COA, MSDS
• Shelf Life: 24 Months
• Storage: Cool Dry Area
• Grade: Pharmaceutical Grade
• CAS No.: 122111-03-9
• Sample: Avaliable
• Service: OEM
• MOQ: 10g
• Assay: 99%Min HPLC
• Test Method: HPLC
• Einecs No.: 601-823-3
• Water Solubility: Soluble in Water
• Transport Package: Boil Bag
• Specification: HPLC 99%min
• Trademark: TGY
• Origin: Xi′an, Shaanxi, China (Mainland)
• HS Code: 29420000
• Production Capacity: 500kg/Month

Product Description

 

Produact name	Gemcitabine hydrochloride	CAS No.	122111-03-9
Appearance	White powder	MF	C9H12ClF2N3O4
Ordor	ordorless	MW	299.66
Melting point	>250ºC	Water solubility	Soluble in water
Specification	99.0%min	Test method	HPLC
Brand	TGY	QC	ISO9001:2008,GMP
Storage	Store in a clean, cool, dry area; keep away from strong, direct light.
Shelf life	2 years when properly stored.
Package	1kg/bag,25kg/drum.
Delivery	Within 3-5 days after payment.

What's the Gemcitabine hydrochloride?

Gemcitabine hydrochloride is a synthetic novel difluoro nucleoside drug that is anti-metabolic and antineoplastic. 
Suitable for the treatment of inoperable advanced or metastatic pancreatic cancer and the treatment of locally advanced or metastatic non-small cell lung cancer, and the treatment for mid-term and advanced non-small cell lung cancer, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.

Don't hesitate to contact us for latest COA and Test Report.

Gemcitabine is a chemotherapy medication used to treat a number of types of cancer. This includes breast cancer, non-small cell lung cancer, pancreatic cancer, bladder cancer, and biliary tract cancer. It is used by injection into a vein. Gemcitabine is used in various carcinomas: non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer. It is being investigated for use in esophageal cancer, and is used experimentally in lymphomas and various other tumor types. Gemcitabine is administered by the intravenous route, since it is extensively metabolized by the gastrointestinal tract.